SPTX (Seaport Therapeutics) EV-to-OCF: (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SPTX Seaport Therapeutics Inc SPTX
11 GF Score
Price $24.04
! 2 Warning Signs
View Full Analysis

What is Seaport Therapeutics EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Seaport Therapeutics's Enterprise Value is $1,014.84 Mil. Seaport Therapeutics does not have enough years/quarters to calculate its Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Seaport Therapeutics's EV-to-OCF at this moment.

The historical rank and industry rank for Seaport Therapeutics's EV-to-OCF or its related term are showing as below:

SPTX' s EV-to-OCF Range Over the Past 10 Years
Min: -13.4   Med: 0   Max: -12.59
Current: -13.02

During the past 2 years, the highest EV-to-OCF of Seaport Therapeutics was -12.59. The lowest was -13.40. And the median was .

SPTX's EV-to-OCF is ranked better than
74.57% of 1408 companies
in the Biotechnology industry
Industry Median: -3.66 vs SPTX: -13.02

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-19), Seaport Therapeutics's stock price is $24.04. Seaport Therapeutics does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025. Therefore, GuruFocus does not calculate Seaport Therapeutics's PE Ratio (TTM) at this moment.

Seaport Therapeutics  (NAS:SPTX) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Seaport Therapeutics's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=24.04/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Seaport Therapeutics EV-to-OCF Related Terms

Seaport Therapeutics EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Seaport Therapeutics's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seaport Therapeutics EV-to-OCF Chart

Seaport Therapeutics Annual Data
Trend Dec24 Dec25
EV-to-OCF
0.00 0.00

Seaport Therapeutics Semi-Annual Data
Dec24 Dec25
EV-to-OCF 0.00 0.00

SPTX vs SVRA, DRTS, FBRX: EV-to-OCF Comparison

For the Biotechnology subindustry, Seaport Therapeutics's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Seaport Therapeutics EV-to-OCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seaport Therapeutics's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Seaport Therapeutics's EV-to-OCF falls into.


SPTX
11GF Score
Seaport Therapeutics Inc SPTX
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seaport Therapeutics EV-to-OCF Calculation

Seaport Therapeutics's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=1014.837/
=

Seaport Therapeutics Business Description

Address 101 Seaport Boulevard, Floor 12, Boston, MA, USA, 02210
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
11GF Score

Get the complete analysis for SPTX

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.04
Price